Press Release
BOYDSense diabetes device places among top innovations at 2019 RESI Innovation Challenge
--Company’s non-invasive breath analysis technology recognized for its innovation and potential to disrupt glucose monitoring industry. San Bruno, Calif. –  October 29, 2019 – Medical technology company BOYDSense, Inc. has returned from the RESI (Redefining Early Stage Investments) conference in Boston with a second-place finish in the RESI Innovation Challenge and myriad accolades from both investors and […]